title: New Zealand's pharmaceutical reference-pricing strategy may backfire.
authors.forename: D
authors.initials: D
authors.lastname: Menkes
mesh_terms: D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D009520:New Zealand